Record Pace of Coronavirus Trials Could Be New Normal for Vaccines
- 66 days from genetic sequencing to clinical trial a new vaccine record
- Process could have been faster if SARS, MERS research hadn’t waned
This article is for subscribers only.
A potential Covid-19 vaccine’s recording-breaking pace to clinical trial could become the new normal as researchers start looking for vaccines before new infections even break out.
The potential is there to break the decade-long timeline to develop new vaccines, making health professionals more nimble in the face of evolving threats. And it could have happened even sooner if the investment in studying SARS and MERS didn’t dry up when those outbreaks went away, scientists said.